Alternate-Day Buprenorphine Administration. Phase IV
Alternate-Day Buprenorphine Administration. Phase IV
The purpose of this study is to determine if three times a subject's daily maintenance dose will hold for 72 hours without changes in agonist and antagonist effects.
Please contact site for information.